comparemela.com
Home
Live Updates
First-Line HER2+ Metastatic Breast Cancer Trials in Focus : comparemela.com
First-Line HER2+ Metastatic Breast Cancer Trials in Focus
Heather McArthur, MD, emphasizes the influence of recent and ongoing clinical trials, specifically DESTINY-Breast09 and HER2CLIMB-05, in steering the treatment paradigm in 1st-line HER2-positive metastatic breast cancer.
Related Keywords
Heather Mcarthur
,
,
Treatment Approach
,
Positive Breast Cancer
,
Metastatic Breast Cancer Trials
,
comparemela.com © 2020. All Rights Reserved.